CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 41 enrolled
Drug / intervention
Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD - ECT Multi-Channel Stimulation Interfacedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04621786
NCT04621786N/ACompleted
CompareCT.gov

Electroconvulsive Therapy Amplitude Titration for Improved Clinical Outcomes in Late Life Depression

University of New Mexico·interventional·Posted Nov 9, 2020·Updated Jan 11, 2024

In Brief

A clinical study evaluating Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD - ECT Multi-Channel Stimulation Interface for Major Depressive Disorder. Completed, enrolled 41 participants across 1 site.

Detailed Summary

This study is focused on advancing ECT treatment for older adults with depressive disorders by refining neuromodulation stimulus parameters to improve efficacy and cognitive safety.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesUnited States
CollaboratorsThe Zucker Hillside Hospital, National Institute of Mental Health (NIMH), The Mind Research Network, University of Texas Southwestern Medical Center

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 9, 2020
Enrollment StartMar 1, 2021
Primary CompletionDec 1, 2022
Study CompletionDec 15, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.6 years ago

Interventions

Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD - ECT Multi-Channel Stimulation Interfacedevice

The Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD-ECT Multi-Channel Stimulation Interface will reduce ECT current amplitude for amplitude-seizure titration.